Topic

Articles

Cliodhna McDonough-Stevens looks at what the COVID-19 pandemic might mean for the future of cell and gene therapy across Europe.

Has COVID-19 Opened up the Route to Market for Cell and Gene Therapy?

Wesam Badran is National Solutions Manager, UK & Ireland, BD.

Wesam Badran looks at how the UK NHS can collaborate with pharma and med-tech partners to encourage digital innovation.

Realizing the NHS’s Digital Potential

Summits, proposals outline advice on response to future pandemics.

COVID Blame Games Give Way to Lesson Learning

Adnan Jamil is a Senior Consultant at Iperion, now part of Deloitte. Iperion’s approach to assessing companies’ IDMP maturity has been standardized and fine-tuned based on leading subject-matter expertise on regulatory information management, data submissions (e.g., IDMP, xEVMPD), and extensive first-hand experience from projects with a broad spectrum of Life Sciences clients.

How pharma firms assess their readiness for IDMP (Identification of Medicinal Products) is important for meeting compliance requirements and ensuring they are prepared for the digital product information management future, writes Adnan Jamil.

Assessing IDMP Maturity

Pandemic triggers urgency around supply chain initiatives.

Bringing a European Focus to Drug  Import Vulnerabilities

The European Commission’s Genetically Modified Organism (GMO) legislation hurts Europe’s ability to attract clinical trials and delays patient access to transformative medicines, say European industry associations.

Industry Groups Call for Advanced Therapies to be Exempt from EU GMO Legislation

Becton, Dickinson and Company is to build a $200 million high-tech manufacturing facility in Zaragoza, Spain. 

New BD Plant in Spain Will Add Capacity to Support Vaccination Campaigns

Draft plan looks beyond the immediate European health challenges.

Long-View Innovation Hopes for Pharma Policy in the EU 

Latest proposal explores boosting the powers of the EMA.

COVID-19 Catalyzing Changes in European Medicines Regulation

Remco Munnik is Associate Director at Iperion, a globally-operating life sciences consultancy firm which is paving the way to digital healthcare, and as such strongly committed to contributing to the actual implementation of the ISO IDMP standards. www.iperion.comRemco.munnik@iperion.com 

The European Medicines Agency (EMA) has published a guide to implementing IDMP data standards that will be ”a game changer” for the life sciences sector. Remco Munnik, who has been working with the EU focus group creating the EU IDMP Implementation Guide version 2, provides the inside track on the implications for life sciences companies.